Garden Valley and Stewart Road
Roseburg, OR 97471 ·
14,550 SF · Retail For Sale
Rare West Coast Walgreens - 65k Cars per Day
|Building Size||14,550 SF||Cap Rate||6.50%|
|Property Sub-type||Free Standing Bldg||Year Built||2011|
|Property Use Type||Net Lease Investment with 10+ years left on lease||Lot Size||1 AC|
|Listing ID: 17000149||Date Created: 01/28/2011||Last Updated: 12/05/2011|
This new Walgreens sits on the corner of Garden Valley and Stewart Road which benefits from traffic counts of over 60,000 cars per day. This intersection is generally considered to be located at Main and Main in Roseburg.
Walgreens opened its first store in Roseburg in late 2008, which located approximately 1.3 miles east of this new store. The fact that Walgreens is moving forward with a second store in town indicates that Walgreens anticipates strong sales volumes based on the strong performance of the other location during the first couple of years of operations. Rite Aid is the only national drugstore competition in town; there is no CVS in the vicinity.
Located in Southwestern Oregon, Roseburg is the gateway to Crater Lake National Park. The town has flourished as a result of both its proximity to the park, its plethora of recreational opportunities and a growing wine industry. Smalll town feel with big town amenities.
Roseburg is a part of the hundred valleys of the Umpqua. In Roseburg, you can climb a mountain, raft a river or catch a salmon and still enjoy great restaurants and shopping--all in in some of the most picturesque areas of the Pacific Northwest.
For the more leisure inclined, Roseburg offers a booming wine country. The Umpqua wine region is well known for its high-quality Burgundian wine varieties like Pinot Noir and Chardonnay and Bordeaux varieties such as Cabernet Sauvignon and Merlot.
- Very rare West Coast Walgreens
- Great corner with over 60,000 cars per day
- Important strategic location for Walgreens
- Lease and rent start August 2011
- Walgreens corporate guarantee (NYSE:WAG)
- Investment grade credit (S&P A+; Moody' s Aa3)